Joel Yeshman

Joel Yeshman has a diverse work experience in finance and accounting. Joel is currently working as a Senior Director of Finance at ReNAgade Therapeutics since September 2021. Prior to this role, they served as a Corporate Controller at EBI Consulting from April 2020 to September 2021.

Before joining EBI Consulting, Joel worked at SQZ Biotechnologies, where they held multiple roles. Joel started as a Senior Accountant in September 2017 and later transitioned to the position of Senior Manager of Accounting and Finance from July 2018 to July 2019. Joel then took on the role of Associate Director of Accounting and Finance from July 2019 to April 2020.

Joel's previous experience includes working as a Senior Accountant at Agios Pharmaceuticals from January 2017 to September 2017 and as a Staff Accountant from November 2015 to January 2017. Joel began their career as an Audit Associate at CBIZ MHM, LLC, where they worked from January 2014 to November 2015.

Before entering the finance and accounting field, Joel worked as a Paralegal at Harmon Law Offices from July 2010 to May 2013.

Throughout their career, Joel has gained expertise in financial management, accounting, and auditing. Joel has effectively held various leadership positions and has exhibited a strong track record of success in the field.

Joel Yeshman pursued their education at the University of Connecticut School of Business from 2006 to 2010, where they obtained a Bachelor of Science (B.S.) in Real Estate and Urban Economics. Later, from 2013 to 2014, they attended Northeastern University's Graduate School of Professional Accounting, earning both a Master of Business Administration (MBA) and a Master of Science in Accounting (MSA).